Prelude Capital Management’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-56,018
| Closed | -$1.67M | – | 1544 |
|
|
2025
Q3 | $1.67M | Buy |
56,018
+19,488
| +53% | +$650K | 0.13% | 200 |
|
|
2025
Q2 | $1.09M | Buy |
36,530
+7,826
| +27% | +$226K | 0.11% | 238 |
|
|
2025
Q1 | $876K | Sell |
28,704
-52,741
| -65% | -$1.78M | 0.07% | 343 |
|
|
2024
Q4 | $3.23M | Sell |
81,445
-40,119
| -33% | -$1.56M | 0.2% | 102 |
|
|
2024
Q3 | $4.71M | Buy |
121,564
+17,579
| +17% | +$711K | 0.29% | 70 |
|
|
2024
Q2 | $4.37M | Buy |
+103,985
| New | +$3.55M | 0.3% | 74 |
|
|
2020
Q4 | – | Sell |
-250
| Closed | -$10K | – | 1939 |
|
|
2020
Q3 | $10K | Buy |
+250
| New | +$11K | ﹤0.01% | 1459 |
|
|
2020
Q1 | – | Sell |
-1,700
| Closed | -$70K | – | 1997 |
|
|
2019
Q4 | $70K | Buy |
+1,700
| New | +$71.6K | ﹤0.01% | 1230 |
|
|
2019
Q2 | – | Sell |
-179
| Closed | -$8K | – | 2114 |
|
|
2019
Q1 | $8K | Buy |
179
+49
| +38% | +$2.5K | ﹤0.01% | 1546 |
|
|
2018
Q4 | $6K | Buy |
+130
| New | +$7.8K | ﹤0.01% | 1570 |
|
|
2018
Q3 | – | Sell |
-239
| Closed | -$13K | – | 2015 |
|
|
2018
Q2 | $13K | Buy |
+239
| New | +$11K | ﹤0.01% | 1442 |
|
|
2017
Q4 | – | Sell |
-2,111
| Closed | -$65K | – | 1690 |
|
|
2017
Q3 | $65K | Buy |
2,111
+311
| +17% | +$8.46K | 0.01% | 1018 |
|
|
2017
Q2 | $51K | Sell |
1,800
-10,643
| -86% | -$257K | ﹤0.01% | 998 |
|
|
2017
Q1 | $299K | Buy |
12,443
+9,401
| +309% | +$230K | 0.03% | 433 |
|
|
2016
Q4 | $77K | Buy |
3,042
+1,887
| +163% | +$49.6K | 0.01% | 908 |
|
|
2016
Q3 | $35K | Sell |
1,155
-1,912
| -62% | -$52.5K | ﹤0.01% | 1161 |
|
|
2016
Q2 | $72K | Buy |
3,067
+1,167
| +61% | +$25.6K | 0.01% | 872 |
|
|
2016
Q1 | $35K | Sell |
1,900
-800
| -30% | -$15.1K | ﹤0.01% | 1033 |
|
|
2015
Q4 | $55K | Buy |
2,700
+1,400
| +108% | +$29.7K | 0.01% | 1022 |
|
|
2015
Q3 | $28K | Buy |
1,300
+1,100
| +550% | +$25.8K | ﹤0.01% | 1188 |
|
|
2015
Q2 | $5K | Sell |
200
-1,900
| -90% | -$47.7K | ﹤0.01% | 1624 |
|
|
2015
Q1 | $55K | Sell |
2,100
-1,000
| -32% | -$23.8K | 0.01% | 1241 |
|
|
2014
Q4 | $69K | Sell |
3,100
-10,010
| -76% | -$212K | 0.01% | 1149 |
|
|
2014
Q3 | $238K | Buy |
13,110
+6,710
| +105% | +$134K | 0.03% | 641 |
|
|
2014
Q2 | $137K | Buy |
6,400
+5,000
| +357% | +$107K | 0.02% | 920 |
|
|
2014
Q1 | $32K | Sell |
1,400
-150
| -10% | -$3.66K | ﹤0.01% | 1561 |
|
|
2013
Q4 | $38K | Sell |
1,550
-200
| -11% | -$4.72K | 0.01% | 1133 |
|
|
2013
Q3 | $42K | Buy |
+1,750
| New | +$37.5K | 0.01% | 958 |
|
Other funds holding SRDX
Prelude Capital Management's SRDX Position: Q4 2025 in Review
Prelude Capital Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 56,018 shares — an estimated $1.67M sold.
Prelude Capital Management first reported a position in SRDX in Q3 2013 and held it in 28 quarters. The position peaked at $4.71M in Q3 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Prelude Capital Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Prelude Capital Management sold 56,018 Surmodics shares in Q4 2025, an estimated $1.67M.
- Prelude Capital Management first reported a position in Surmodics in Q3 2013 and held it in 28 quarters.
- Prelude Capital Management's Surmodics position peaked at $4.71M in Q3 2024.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.